 | |
- close
- close
|
Business Wire
Nov 5
Comment
Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,592,441 to Rosetta Genomics. The patent
Business Wire
Nov 3
Comment
Rosetta Genomics, Ltd. (Nasdaq: ROSG), a leading developer of microRNA-based molecular diagnostics, today announced the appointment of Kenneth A. Berlin to the position of president and chief executive officer, effective November 2, 2009. Rosetta
Business Wire
Oct 22
Comment
Rosetta Genomics, Ltd. (NASDAQ:ROSG), a leading developer of microRNA-based molecular diagnostics, and Genetic Technologies Limited (GTG) (NASDAQ:GENE) (ASX:GTG), the leading private genetic testing laboratory in Australia, announced today the
PR Newswire
Oct 15
Comment
SAN DIEGO, Oct. 15 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the nationwide commercial launch of three new cancer diagnostic products: ProOnc TumorSource Dx, ProOnc Squamous Dx
Business Wire
Sep 29
Comment
Rosetta Genomics, Ltd. (NASDAQ:ROSG) a leading developer of microRNA-based molecular diagnostics, announced that management will present a corporate update at the 2009 Maxim Group Growth Conference today, Tuesday, September 29, 2009 at 02:30 p.m.,
newratings.com
Sep 9
Comment
NEW YORK, September 9 (newratings.com) - Analysts at Cantor Fitzgerald downgrade Rosetta Genomics (ticker: ROSG) from "buy" to "hold." [more]
Business Wire
Sep 8
Comment
Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer of microRNA-based molecular diagnostics, today reported financial results for the three and six months ended June 30, 2009. Highlights of the second quarter of 2009 and subsequent weeks
Business Wire
Sep 8
Comment
Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer of microRNA-based molecular diagnostics, and AXA Diagnostics, a privately owned company that markets specialized diagnostic tests, announced today the signing of an exclusive distribution
Business Wire
Sep 2
Comment
Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer of microRNA-based molecular diagnostics, announced that Amir Avniel, president and chief executive officer, will be presenting a corporate update at the Rodman & Renshaw 11th Annual
Business Wire
Sep 2
Comment
Rosetta Genomics (NASDAQ: ROSG) today announced it will release financial results for the second quarter of 2009 on September 8, 2009 after the close of NASDAQ trading, and will host a conference call and webcast to discuss those results and answer
|
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
|
||
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
ROSG AT A GLANCE
References
| ||||||
|
|
